New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia by identifying the blood cancer's reliance on a specific signaling pathway ...

New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...

To our knowledge, this is the largest study to date to comprehensively evaluate NK-t-AML and provides a framework that may inform our understanding of NK-t-AML disease biology and could potentially ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...

A series of blood tests, procedures, and imaging tests can help diagnose acute myeloid leukemia (AML). Additionally, these tests can also determine its subtype and help identify the best treatment ...

Phase II study of omacetaxine (OM) and low-dose AraC (LDAC) in older patients with acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS). This is an ASCO Meeting Abstract from ...

Acute Myeloid Leukemia (AML) is a form of cancer that affects the blood and bone marrow and grows quite rapidly. It begins when immature white blood cells known as myeloblasts start to undergo ...

AML Awareness Month is marked each June. In India, where infectious diseases dominate public health narratives, a quieter and deadlier crisis is unfolding- Acute Myeloid Leukemia (AML). About 10-15% ...